NOVAVAX H-1B Visa Sponsorship & Salary Data

The median H-1B salary at NOVAVAX is $125,000, based on 85 certified filings from FY 2020 to FY 2025. This is 4% higher than the national H-1B median salary of $120,000. Compensation at NOVAVAX reflects their market positioning, with entry-level roles starting around $103,333 and senior positions reaching $164,400 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at NOVAVAX range from $85,000 at the 10th percentile to $164,400 at the 90th percentile, showing a $79,400 spread across experience levels and roles. The 25th percentile is $103,333 and the 75th percentile is $142,000.

Yes, NOVAVAX actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 85 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 85 certified applications and a 0% denial rate, NOVAVAX maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), NOVAVAX filed 12 H-1B applications, with 12 certified and 0 denied. Over 6 years of data, NOVAVAX has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

NOVAVAX's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 85 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating NOVAVAX as a potential H-1B sponsor.

This is an excellent approval rate, indicating NOVAVAX has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

NOVAVAX sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 85 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles NOVAVAX most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at NOVAVAX:

The most frequently sponsored role is Statistical Programmer III with 5 filings at a median salary of $125,000. This is followed by Research Scientist II (5 filings) and Associate Research Scientist.

NOVAVAX's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where NOVAVAX sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top NOVAVAX H-1B locations:

The largest H-1B hub for NOVAVAX is Gaithersburg, MD with 53 filings at a median salary of $115,000. The highest-paying location is St. Johns, FL at $180,000 median. Salaries range from $80,000 to $180,000 across office locations.

NOVAVAX's median H-1B salary has increased by +1% from FY 2020 ($136,000) to FY 2025 ($137,513). Tracking salary trends over time reveals how NOVAVAX adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at NOVAVAX.

Year-by-year breakdown:

• FY 2021: $108,410 (24 certified)
• FY 2022: $115,000 (18 certified)
• FY 2023: $135,850 (14 certified)
• FY 2024: $135,000 (15 certified)
• FY 2025: $137,513 (12 certified)

NOVAVAX has maintained steady salary growth for H-1B positions over this period.

NOVAVAX primarily files H-1B applications at Wage Level II, accounting for 36% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making NOVAVAX's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

NOVAVAX has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

NOVAVAX's median H-1B salary of $125,000 is 4% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating NOVAVAX's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare NOVAVAX's offerings with similar companies in your field for a more accurate assessment.

NOVAVAX offers above-average H-1B compensation. Combined with their 85 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. NOVAVAX files 21% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 85 certified filings, NOVAVAX invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.